Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetics and Molecular Pathology, |
RCV003447827 | SCV004175661 | uncertain significance | Autism spectrum disorder | 2021-01-08 | criteria provided, single submitter | clinical testing | The DOCK4 gene encodes a protein which acts as a guanine nucleotide exchange factor and has been associated with regulating various processes of brain development. Recent studies have suggested DOCK4 is associated with neuropsychiatric disorders including autism spectrum disorder, dyslexia and schizophrenia (PMID: 32009906, 20346443, 31388105). The DOCK4 c.2689C>T variant is a single nucleotide change in exon 25 of the DOCK4 gene, which is predicted to change the amino acid proline at position 897 in the protein to serine. This variant is de novo but the gene has only few pathogenic variants, mainly deletions, reported to date (PS2_moderate). The variant has not been reported in dbSNP and is absent from population databases (PM2). It has not been reported in the ClinVar or HGMD disease databases. Computational predictions support a deleterious effect on the gene or gene product (PP3). The DOCK4 c.2689C>T variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE (PS2_moderate, PM2, PP3) |